Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Toshimitsu Yamaoka(Showa University), Yasutsuna Sasaki(Showa University)
Cited by 29
Related Papers
Receptor Tyrosine Kinase-Targeted Cancer Therapy
|International Journal of Molecular Sciences|2018|285
Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury
|International Journal of Molecular Sciences|2019|37